PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$1.05B
1-Year Est. Return
89.76%
This Fund
S&P 500
1 Year Est. Return
+89.76%
AUM
$1.05B
AUM Growth
+$140M
(+15%)
Holding
111
Top Buys
| 1 | +$28.6M | |
| 2 | +$26.9M | |
| 3 | +$15.4M | |
| 4 |
Waters Corp
WAT
|
+$15.4M |
| 5 |
Mettler-Toledo International
MTD
|
+$15.3M |
Top Sells
| 1 | +$17.7M | |
| 2 | +$15.5M | |
| 3 | +$11.4M | |
| 4 |
Castle Biosciences
CSTL
|
+$10.5M |
| 5 |
Viridian Therapeutics
VRDN
|
+$10M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Adaptive Biotechnologies
ADPT
$2.18B
| $6.52M | 0.62% |
+401,730
|
|
||
52
Biogen
BIIB
$27.1B
| $6.23M | 0.59% |
35,425
-94,740
|
|
||
53
uniQure
QURE
$1.13B
| $6.16M | 0.59% |
257,382
-87,974
|
|
||
|
DAWN
54
DELISTED
Day One Biopharmaceuticals
DAWN
| $6.02M | 0.57% |
645,544
+343,798
|
|
||
55
Immunome
IMNM
$2.67B
| $5.97M | 0.57% |
277,812
-73,319
|
|
||
|
56
Castle Biosciences
CSTL
$741M
| $5.86M | 0.56% |
150,558
-325,010
|
|
||
57
Alphatec Holdings
ATEC
$1.65B
| $5.83M | 0.56% |
277,181
-419,799
|
|
||
58
Transmedics
TMDX
$3.83B
| $5.5M | 0.52% |
+45,174
|
|
||
59
Schrodinger
SDGR
$870M
| $5.35M | 0.51% |
298,939
-41,248
|
|
||
60
QuidelOrtho
QDEL
$789M
| $5.27M | 0.5% |
184,491
-68,326
|
|
||
61
CareDx
CDNA
$1.09B
| $5.2M | 0.5% |
+276,154
|
|
||
62
GeneDx Holdings
WGS
$2.01B
| $5.11M | 0.49% |
39,272
-5,978
|
|
||
63
Vera Therapeutics
VERA
$2.7B
| $5.09M | 0.48% |
100,564
+3,827
|
|
||
64
Absci
ABSI
$612M
| $5.09M | 0.48% |
+1,458,652
|
|
||
65
Amylyx Pharmaceuticals
AMLX
$1.89B
| $4.61M | 0.44% |
381,760
-197,414
|
|
||
66
InspireMD
NSPR
$58.5M
| $4.3M | 0.41% |
2,416,518
-24,115
|
|
||
67
Veracyte
VCYT
$2.74B
| $4.22M | 0.4% |
100,269
-122,796
|
|
||
68
Precigen
PGEN
$1.46B
| $4.19M | 0.4% |
1,002,826
-1,098,889
|
|
||
69
Spyre Therapeutics
SYRE
$6.01B
| $4.08M | 0.39% |
124,485
-76,268
|
|
||
70
UroGen Pharma
URGN
$1.17B
| $3.95M | 0.38% |
168,768
-233,827
|
|
||
71
Align Technology
ALGN
$13.6B
| $3.95M | 0.38% |
+25,285
|
|
||
72
Structure Therapeutics
GPCR
$3.23B
| $3.83M | 0.36% |
+55,000
|
|
||
73
4D Molecular Therapeutics
FDMT
$480M
| $3.78M | 0.36% |
503,431
+303,431
|
|
||
74
RxSight
RXST
$299M
| $3.66M | 0.35% |
351,655
-29,058
|
|
||
75
ADMA Biologics
ADMA
$2.62B
| $3.65M | 0.35% |
+200,000
|
|